Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
54%
OVERLAP
BY WEIGHT
29
# OF OVERLAPPING
HOLDINGS
FHLC
349
HOLDINGS
9%
ALSO IN PBPH
PBPH
57
HOLDINGS
57%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus PBPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PBPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.6% | 16.9% | 14.6% |
|
JOHNSON & JOHNSON | 8.5% | 9.3% | 8.5% |
|
ABBVIE INC | 6.7% | 7.4% | 6.7% |
|
MERCK & CO. INC. | 4.8% | 5.2% | 4.8% |
|
AMGEN INC | 3.2% | 4.4% | 3.2% |
FHLC Overweight Relative to PBPH
|
UNITEDHEALTH GROUP INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
ABBOTT LABORATORIES | 2.4% |
|
INTUITIVE SURGICAL INC | 2.0% |
|
DANAHER CORP | 1.9% |
 |
MEDTRONIC PLC | 1.6% |
|
MCKESSON CORP | 1.5% |
|
CVS CAREMARK CORP | 1.5% |
|
STRYKER CORP | 1.3% |
|
ELEVANCE HEALTH INC | 1.2% |
FHLC Underweight Relative to PBPH
 |
ASTRAZENECA PLC | -4.8% |
 |
NOVARTIS AG | -4.2% |
 |
NOVO NORDISK A/S-B | -2.5% |
|
ELI LILLY & CO | -2.3% |
 |
SANOFI-AVENTIS | -1.9% |
|
GSK PLC | -1.8% |
|
GILEAD SCIENCES INC | -1.4% |
 |
CSL LIMITED | -1.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -1.3% |
 |
ARGEN-X SE | -1.1% |